Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Mark L. Messonnier"'
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156737 (2016)
To determine the optimal level of vaccination coverage defined as the level that minimizes total costs and explore how economic results change with marginal changes to this level of coverage.A susceptible-infected-recovered-vaccinated model designed
Externí odkaz:
https://doaj.org/article/4cddab9de7234b44b31cfd356f84ade5
Autor:
Sanghamitra M. Misra, Mark L. Messonnier, Leila C. Sahni, Fangjun Zhou, Weiwei Chen, Julie A. Boom
Publikováno v:
Clin Pediatr (Phila)
This study aims to evaluate the cost-benefit of vaccination services, mostly partial series administration, provided by a mobile clinic program (MCP) in Houston for children of transient and low-income families. The study included 469 patients who vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca35d32a9cca70b35ae82e83e0b2b1d
https://doi.org/10.1177/0009922820908586
https://doi.org/10.1177/0009922820908586
Publikováno v:
J Public Health (Bangkok)
OBJECTIVES: Evaluate different non-continuous temperature monitoring practices for detection of out-of-range temperatures (above or below the recommended temperature range of 2–8°C for refrigeration units), which are called excursions, within vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ce1501bcd1cff83e3c24dd67085698
https://europepmc.org/articles/PMC9345596/
https://europepmc.org/articles/PMC9345596/
Publikováno v:
Health Econ
Vaccine purchase cost has grown substantially over the last few decades. A closer look at vaccine prices reveals that not all vaccines shared the same increasing pattern. Various factors, such as vaccine attributes, competition, and supply shortages,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3e98a8bfdc61c2006ef13edc52219b
https://doi.org/10.1002/hec.3539
https://doi.org/10.1002/hec.3539
Autor:
Mark L. Messonnier, Aparna Ramakrishnan, David K. Kim, Angela M Rose, Lisa A. Prosser, Norma-Jean Simon, Tara A. Lavelle, Achamyeleh Gebremariam, Shannon Stokley
Publikováno v:
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-12 (2019)
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-12 (2019)
Background Adult and adolescent vaccination rates are far below coverage targets in the United States. Our objective was to identify the most influential factors related to vaccine uptake among adults, adolescents, and parents of adolescents (parents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464ace091e754405b65f405c8c96ed04
https://doi.org/10.1186/s41687-019-0135-0
https://doi.org/10.1186/s41687-019-0135-0
Publikováno v:
Vaccine. 34:1832-1838
Introduction The United States experienced a substantial increase in reported pertussis cases over the last decade. Since 2005, persons 11 years and older have been routinely recommended to receive a single dose of tetanus toxoid, reduced diphtheria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d840cf48cab1c627bd1779d337bf5dc
https://doi.org/10.1016/j.vaccine.2016.02.027
https://doi.org/10.1016/j.vaccine.2016.02.027
Publikováno v:
Vaccine. 36(43)
Purpose Measure the preferences of decision makers and researchers associated with the Advisory Committee on Immunization Practices (ACIP) regarding the recommended format for presenting health economics studies to the ACIP. Methods We conducted key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d612e6eee489d20e2eac07e5022cea8a
https://pubmed.ncbi.nlm.nih.gov/30236631
https://pubmed.ncbi.nlm.nih.gov/30236631
Autor:
Adriana S. Lopez, Jay Wenger, Margaret M. Cortese, Lance E. Rodewald, Li Yan Wang, Trudy V. Murphy, Fangjun Zhou, Mark L. Messonnier, Abigail Shefer, Matthew R. Moore
Publikováno v:
Pediatrics. 133:577-585
OBJECTIVES:To evaluate the economic impact of the 2009 routine US childhood immunization schedule, including diphtheria and tetanus toxoids and acellular pertussis, Haemophilus influenzae type b conjugate, inactivated poliovirus, measles/mumps/rubell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85369a0ba178211c33fa4a9f2be8a15a
https://doi.org/10.1542/peds.2013-0698
https://doi.org/10.1542/peds.2013-0698
Autor:
Garrett R. Beeler Asay, Bo-Hyun Cho, Mark L. Messonnier, Derek S. Brown, Suchita A. Lorick, Sarah Arnold, Ricardo Basurto-Davila
Publikováno v:
Vaccine. 32:1043-1048
The use of alternative venues beyond physician offices may help to increase rates of population influenza vaccination. Schools provide a logical setting for reaching children, but most school-located vaccination (SLV) efforts to date have been limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb17bc8a9972c4344ac79da4355836fc
https://doi.org/10.1016/j.vaccine.2014.01.003
https://doi.org/10.1016/j.vaccine.2014.01.003
Autor:
Lee M. Hampton, Mark L. Messonnier, Fangjun Zhou, Charles Stoecker, Ruth Link-Gelles, Matthew R. Moore
Publikováno v:
Pediatrics. 132:e324-e332
BACKGROUND AND OBJECTIVE: Although effective in preventing pneumococcal disease, 13-valent pneumococcal conjugate vaccine (PCV13) is the most expensive vaccine on the routinely recommended pediatric schedule in the United States. We examined the cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fdb3e58e0d7b75ab931e958c99d4cbf
https://doi.org/10.1542/peds.2012-3350
https://doi.org/10.1542/peds.2012-3350